A detailed history of Empire Financial Management Company, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Empire Financial Management Company, LLC holds 1,960 shares of NVO stock, worth $219,422. This represents 0.09% of its overall portfolio holdings.

Number of Shares
1,960
Previous 1,960 -0.0%
Holding current value
$219,422
Previous $252 Million 11.17%
% of portfolio
0.09%
Previous 0.08%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 15, 2024

BUY
$87.78 - $105.45 $172,048 - $206,682
1,960 New
1,960 $203 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $253B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Empire Financial Management Company, LLC Portfolio

Follow Empire Financial Management Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Empire Financial Management Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Empire Financial Management Company, LLC with notifications on news.